The interventional cardiology devices market refers to the sector of the medical device industry that focuses on devices used in the field of interventional cardiology. Interventional cardiology is a specialized branch of cardiology that involves diagnosing and treating cardiovascular diseases using minimally invasive techniques.

Interventional cardiology devices are designed to perform various procedures inside the blood vessels or heart, with the goal of diagnosing and treating conditions such as coronary artery disease, heart valve disorders, congenital heart defects, and peripheral vascular diseases. These devices are typically used in cardiac catheterization procedures, where a thin, flexible tube called a catheter is inserted into a blood vessel and guided to the heart or other relevant areas.

Some common interventional cardiology devices include:

·         Coronary Stents: These are small mesh-like devices used to keep narrowed or blocked coronary arteries open. They are often made of metal or a combination of metal and a drug-coated polymer

·         Catheters: These are thin tubes used for various purposes, such as delivering medications, removing blood clots, or performing angioplasty procedures to open blocked arteries.

·         Balloon Catheters: These catheters have an inflatable balloon at their tip, which can be inflated to open narrowed or blocked blood vessels. They are commonly used in angioplasty procedures.

·         Intravascular Ultrasound (IVUS) Systems: These devices use ultrasound technology to generate real-time images of blood vessels from inside the body. They provide detailed information about the vessel's structure and aid in guiding interventions

·         Embolic Protection Devices: These devices are used to capture and remove debris or blood clots that may dislodge during interventional procedures, preventing them from causing further blockages downstream.

Reduction in Number of Elective Surgeries Impeded Market Growth

The COVID-19 pandemic negatively affected the market in 2020 due to elective surgical procedures across the globe, significantly affecting the global market. According to PLOS, in September 2022, in Michigan, the total PCI procedural volume from March to December 2020 declined by 15.2% compared to 2019. In 2021, all elective and interventional surgeries were conducted in several countries across the globe. Preference for interventional procedures due to non-invasive and infection control among patients is set to propel the market growth.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them in addressing various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.